Abiopharma

News list

(30% Negative) PROVENTION BIO, INC. (PRVB) Announces Delay in involved Trials for his ongoing exceptional c

Full text

News bot Oct. 2, 2025, 3:43 a.m.
📋 PROVENTION BIO, INC. (PRVB) - Clinical Trial Update

Filing Date: 2022-06-03

Accepted: 2022-06-03 07:11:46

Event Type: Clinical Trial Update
Event Details:
Provention Bio Inc (the company became a subdivision of the company Sanofi ADR (SNY)) (PRVB) Announces Clinical Trial Update Provention Bio Inc (the company became a subdivision of the company Sanofi ADR (SNY)) (PRVB) provided an update on its clinical development programs. Clinical Development Highlights:
Drug Program: involved, best
Diseases/Conditions: his ongoing exceptional c
Update Type: Trial Timeline Adjustment
Collaboration: the United States Food and Drug Administration
💼 Business Developments:

No business developments data available.
Structured Data:
- Company Name: Provention Bio Inc (the company became a subdivision of the company Sanofi ADR (SNY))
- CIK: 0001695357
- Ticker Symbol: PRVB
- Period End Date: 2022-06-01
- Document Type: 8-K